Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with or without trastuzumab (H) in patients (pts) with HER2-positive breast cancer
   Google Scholar   
Citation:
J Clin Oncol vol 25 (18S) abstr 512
Year:
2007
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
164   3166  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                       
Networks:
 
Study
NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: